Jamel Toppin for ForbesBiotech company Mammoth Biosciences, which uses gene-editing Crispr technology for diagnostic and discovery applications, announced Wednesday that it has signed an exclusive deal with University of California Berkeley to license a new class of Crispr proteins for use in its product line. Berkeley, in a laboratory headed by Crispr pioneer Jennifer Doudna, published a paper outlining their discovery a new type of Crispr protein. In addition to being able to perform some useful gene-editing functions, this protein is also half the size of other Crispr proteins. As part of its terms with Berkeley, Mammoth Biosciences will have exclusive commercial rights to the CasΦ protein, extending the company’s exclusive set of proteins. “We’re really focused on building out the largest and most diverse toolbox of Crispr proteins on Earth,” says Martin.

Source: Forbes August 12, 2020 15:11 UTC